Search results
Results from the WOW.Com Content Network
Diclofenac, sold under the brand name Voltaren among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammatory diseases such as gout. [6] [9] It can be taken orally (swallowed by mouth), inserted rectally as a suppository, injected intramuscularly, injected intravenously, applied to the skin topically, or through eye drops.
In contrast, paracetamol (acetaminophen) is regarded as being safe and well tolerated during pregnancy, but Leffers et al. released a study in 2010, indicating that there may be associated male infertility in the unborn. [92] [93] Doses should be taken as prescribed, due to risk of liver toxicity with overdoses. [94]
It most commonly strikes individuals aged 20–40 years of age, is more common in men than in women, and is more common in white than in black people. This is owing to the high frequency of the HLA-B27 gene in the white population. [11] [12] It can occur in epidemic form. Patients with HIV have an increased risk of developing reactive arthritis ...
While everyone’s comfort level with certain ingredients may differ, Rogers favors a mineral-based formula (specifically, zinc oxide) during pregnancy, particularly for those who are applying it ...
[17] [18] This may be because such women are more likely to ingest substances that are harmful to the fetus. [19] In addition to protecting the fetus, morning sickness may also protect the mother. A pregnant woman's immune system is suppressed during pregnancy, presumably to reduce the chances of rejecting tissues of her own offspring. [20]
The World Health Organization recommends that women with severe hypertension during pregnancy should receive treatment with anti-hypertensive agents. [4] Severe hypertension is generally considered systolic BP of at least 160 or diastolic BP of at least 110. [3] Evidence does not support the use of one anti-hypertensive over another. [15]
Additionally, the time it takes for pregnant women (any stage of pregnancy) to react to a translational disturbance is not significantly different than that of non-pregnant women. [42] This alludes to some sort of stability mechanism that allow pregnant women to compensate for the changes they experience during pregnancy.
The RAQoL was developed by Galen Research, the University of Leeds and the Academic Hospital Maastricht, and was first published in 1997. [5] It was the first patient completed quality of life questionnaire that focused on rheumatoid arthritis [6] and is distinct from other questionnaires as it includes physical contact as a dimension of quality of life. [3]